Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study
- PMID: 17625430
- DOI: 10.1097/01.meg.0000243876.79325.a1
Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study
Abstract
Objectives: To identify risk factors of carcinoma of the extrahepatic biliary tract in men.
Methods: Newly diagnosed and histologically confirmed patients, 35-70 years old, were interviewed between 1995 and 1997 in Denmark, Sweden, France, Germany and Italy. Population controls were frequency-matched by age and region. Adjusted odds ratios and 95%-confidence intervals were estimated by logistic regression.
Results: The analysis included 153 patients and 1421 controls. The participation proportion was 71% for patients and 61% for controls. Gallstone disease was corroborated as a risk factor for extrahepatic biliary tract carcinoma in men (odds ratio 2.49; 95% confidence interval 1.32-4.70), particularly for gall bladder tumors (odds ratio 4.68; 95% confidence interval 1.85-11.84). For a body mass index [height (m) divided by squared weight (kg2)] >30 at age 35 years, an excess risk was observed (odds ratio 2.58; 95% confidence interval 1.07-6.23, reference: body mass index 18.5-25) that was even stronger if the body mass index was >30 for the lowest weight in adulthood (odds ratio 4.68; 95% confidence interval 1.13-19.40). Infection of the gall bladder, chronic inflammatory bowel disease, hepatitis or smoking showed no clear association, whereas some increase in risk was suggested for consumption of 40-80 g alcohol per day and more.
Conclusions: Our study corroborates gallstones as a risk indicator in extrahepatic biliary tract carcinoma. Permanent overweight and obesity in adult life was identified as a strong risk factor for extrahepatic biliary tract carcinoma, whereas we did not find any strong lifestyle-associated risk factors. Inconsistent results across studies concerning the association of extrahepatic biliary tract carcinoma with overweight and obesity may be explained by the different approaches to assess this variable.
Comment in
-
Risk factors for cholangiocarcinoma.Eur J Gastroenterol Hepatol. 2007 Aug;19(8):615-7. doi: 10.1097/MEG.0b013e328224b935. Eur J Gastroenterol Hepatol. 2007. PMID: 17625428 Review.
Similar articles
-
[Tea consumption and risk of biliary tract cancers and gallstone disease: a population-based case-control study in Shanghai, China].Zhonghua Zhong Liu Za Zhi. 2005 Nov;27(11):667-71. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16438888 Chinese.
-
Risk factors for biliary tract cancers.Am J Gastroenterol. 1999 Jan;94(1):149-52. doi: 10.1111/j.1572-0241.1999.00786.x. Am J Gastroenterol. 1999. PMID: 9934746
-
Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification.Cancer Causes Control. 2008 Feb;19(1):33-41. doi: 10.1007/s10552-007-9067-8. Epub 2007 Sep 30. Cancer Causes Control. 2008. PMID: 17906958
-
[Biliary tract tumors].Ann Ist Super Sanita. 1996;32(4):615-9. Ann Ist Super Sanita. 1996. PMID: 9382430 Review. Italian.
-
Biliary tract cancer.Cancer Surv. 1994;19-20:125-37. Cancer Surv. 1994. PMID: 7534623 Review.
Cited by
-
New insights on cholangiocarcinoma.World J Gastrointest Oncol. 2010 Mar 15;2(3):136-45. doi: 10.4251/wjgo.v2.i3.136. World J Gastrointest Oncol. 2010. PMID: 21160821 Free PMC article.
-
Evidence-based clinical practice guidelines for cholelithiasis 2021.J Gastroenterol. 2023 Sep;58(9):801-833. doi: 10.1007/s00535-023-02014-6. Epub 2023 Jul 15. J Gastroenterol. 2023. PMID: 37452855 Free PMC article. Review.
-
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation.J Gastroenterol. 2024 Aug;59(8):732-743. doi: 10.1007/s00535-024-02124-9. Epub 2024 Jun 19. J Gastroenterol. 2024. PMID: 38896254
-
Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.HPB (Oxford). 2011 May;13(5):309-19. doi: 10.1111/j.1477-2574.2010.00286.x. Epub 2011 Mar 10. HPB (Oxford). 2011. PMID: 21492330 Free PMC article.
-
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma.GE Port J Gastroenterol. 2017 May;24(3):114-121. doi: 10.1159/000452691. Epub 2017 Feb 23. GE Port J Gastroenterol. 2017. PMID: 28848795 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources